
AZN
Healthcare · Drug Manufacturers - General · $286.07B market cap
$184.45+0.07 (+0.0%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 30, 2026 | Before the open | 2.60 | 2.79 | +7.3% |
| Jul 27, 2026 | Before the open | 2.50 | 2.63 | +5.2% |
| Apr 29, 2026 | Before the open | 1.27 | 1.29 | +1.6% |
| Feb 10, 2026 | Time not confirmed | — | 1.49 | — |
| Nov 6, 2025 | Before the open | 1.13 | 1.19 | +5.3% |
| Jul 29, 2025 | Before the open | 0.88 | 0.79 | -10.2% |
| Apr 29, 2025 | Before the open | 1.12 | 1.25 | +11.6% |
| Feb 6, 2025 | Before the open | 1.04 | 1.05 | +1.0% |
| Nov 12, 2024 | Before the open | 1.03 | 1.04 | +1.0% |
| Jul 25, 2024 | Before the open | 0.99 | 0.99 | 0.0% |
| Apr 25, 2024 | Before the open | 0.95 | 1.03 | +8.4% |
| Feb 8, 2024 | Before the open | 0.76 | 0.73 | -3.9% |
| Nov 9, 2023 | Before the open | 0.82 | 0.87 | +6.1% |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal,…
| Jul 28, 2023 | Before the open | 0.97 | 1.08 | +11.3% |
| Apr 27, 2023 | Before the open | 0.82 | 0.96 | +17.1% |
| Feb 9, 2023 | Before the open | 0.68 | 0.69 | +1.5% |
| Nov 10, 2022 | Before the open | 0.75 | 0.84 | +12.0% |
| Jul 29, 2022 | Before the open | 1.04 | 0.86 | -17.3% |
| Apr 29, 2022 | Before the open | 1.15 | 0.95 | -17.4% |
| Feb 10, 2022 | Before the open | 0.99 | 0.84 | -15.2% |
| Nov 12, 2021 | Before the open | 0.91 | 0.54 | -40.7% |
| Jul 29, 2021 | Before the open | 0.69 | 0.45 | -34.8% |
| Apr 30, 2021 | Before the open | 0.96 | 0.82 | -14.6% |
| Feb 11, 2021 | Before the open | 0.76 | 0.61 | -19.7% |
| Nov 5, 2020 | Before the open | 0.48 | 0.46 | -4.2% |
| Jul 30, 2020 | Before the open | 0.40 | 0.48 | +20.0% |
| Apr 29, 2020 | Before the open | 0.49 | 0.53 | +8.2% |
| Feb 14, 2020 | Time not confirmed | — | 0.24 | — |
| Oct 24, 2019 | Before the open | 0.41 | 0.50 | +22.0% |
| Jul 25, 2019 | Before the open | 0.31 | 0.37 | +19.4% |
| Apr 26, 2019 | Before the open | 0.38 | 0.45 | +18.4% |
| Feb 14, 2019 | Time not confirmed | — | 0.82 | — |
| Nov 8, 2018 | Before the open | 0.37 | 0.36 | -2.7% |
| Jul 26, 2018 | Before the open | 0.30 | 0.35 | +16.7% |
| May 18, 2018 | Time not confirmed | — | 0.27 | — |
| Feb 2, 2018 | Before the open | 0.56 | 0.65 | +16.1% |